Intl Society of Pharmaceutical Engineers-Delaware Valley Chapter

Nonprofit profile at a glance

EIN
232656185
IRS 990 coverage
2012–2025
Forms available
Form 990 2025, Form 990-EZ 2021
Location
Conshohocken, PA, USA
Phone
2679397561
Rating
75
Verdict
SUPPORTED
Rating confidence
Moderate

Official website

Reported finances

Revenue
$555,213
Expenses
$505,877
Assets
$433,411
Liabilities
$0

Source: IRS Form 990. Selected filing: tax year 2025. Amounts in USD.

Leadership & pay

24 people listed

Executive titles in this filing

  • Sandra Bones (President)
  • Alfredo Padilla (Executive Vice President)
  • Laura-Ann ChinPE (Past President)
  • John Clapham (Vice President, Programs)
  • Timothy Javan (Vice President, Education)
  • Ellen Venezia (Vice President - membership)

People named in this filing

  • Sandra Bones (President)
  • Alfredo Padilla (Executive Vice President)
  • Leta Sledge (Treasurer)

Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.

Source: IRS Form 990. Selected filing: tax year 2025. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

ISPE is dedicated to educating and advancing pharmaceutical manufacturing professionals and their industry. ISPE provides an inviting and neutral environment for experts, technologists, regulators, consultants, and students to exchange ideas and practical experience.

What it reported doing in 2025

ISPE DVC hosts an annual symposium that seeks to promote the latest life sciences industry innovations and manufacturing trends. This science and technology tradeshow integrates participation of professionals from different facets including industry end users, capital project leads, OEMs, EPCMVs, regulatory leaders and service providers. Central to the symposium is an educational track that seeks to highlight the successes across multiple manufacturing sites, current Good Manufacturing Practices (cGMP), global industry trends, facility design challenges, quality and regulatory framework, relevant topics pertaining to Emerging Leaders (ie Automation 101, ATMP 101, etc.) The 2025 event was held on May 28, 2025 and was attended by 969 participants.

Operating model

Revenue model
Earned-program. 100% of the money available for current operations came from fees and other program revenue.
Distribution model
Direct operator. The filing allocates 86% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.

The verdict

SUPPORTED - A large share of available resources goes toward mission work and the filed numbers largely add up. Some filing-based governance responses are negative or unanswered and some filed totals do not add up.

Rating breakdown

  • Financial Efficiency: 74
  • Transparency & Controls: 84
  • Accountability: 64
  • Sustainability: 56
  • Growth: 100

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 79.8%; rating input score 80
  • Program expense ratio: 87.7%; rating input score 88
  • Fundraising efficiency: Limited

Transparency & Controls

  • Consistency checks: 88.9%; rating input score 89; 4th percentile among comparable filings
  • Pay-setting controls: Limited
  • Foreign activity oversight: Limited
  • Grant itemization coverage: 94.5%; rating input score 94; 45th percentile among comparable filings
  • Major donor itemization: Limited
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 100%; rating input score 100; 64th percentile among comparable filings
  • Governance controls: 1 of 7 controls in place; rating input score 14
    • Conflict-of-interest policy: Fail
    • Whistleblower policy: Fail
    • Document-retention policy: Fail
    • CEO compensation review process: NotApplicable
    • Other executive compensation review process: NotApplicable
    • Form 990 shared with the board: Fail
    • Board meeting minutes documented: Pass
    • Audit committee oversight: Missing
    • Independent financial-statement audit: Fail

Sustainability

  • Operating margin: 8.9%; rating input score 54; 54th percentile among comparable filings
  • Total-asset coverage ratio: 0.86; rating input score 38; 38th percentile among comparable filings
  • Liabilities to assets ratio: 0; rating input score 88; 88th percentile among comparable filings
  • Officer compensation ratio: 0%; rating input score 78; 78th percentile among comparable filings

Growth

  • Program expense growth: 13.3% per year; rating input score 100; 67th percentile among comparable filings
  • Revenue growth: 8.7% per year; rating input score 100; 56th percentile among comparable filings
  • Asset growth: 8.4% per year; rating input score 100; 49th percentile among comparable filings

Details

  • Where the money goes: 79.8% of revenue deployed · 87.7% of spending went to programs
  • Governance: 24 of 24 board members independent · 1 of 7 filing controls reported
  • Programs: 5 filed program accomplishments · $444K in reported program spending
  • Leadership: top reported pay $0 · 24 people listed
  • Consistency: 16 of 17 current checks pass · 1 finding to review
  • Schedules: 3 filed schedules · includes grants
  • Filing history: 11 filing years from 2012 to 2025
  • Contacts: How to reach this organization
  • Money network: 1 filed money-flow record
  • Related organizations: 2 filed related-organization links
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • High — Accountability: Governance controls: 5 of 6 not reported.
  • Review — Transparency & Controls: Domestic grant itemization did not reconcile in the filed values.
  • Review — Sustainability: Operating margin scored 54/100.
  • Moderate — Sustainability: Total-asset coverage ratio scored 38/100.